Glucosamine-induced insulin resistance in L6 muscle cells

Diabetes, Obesity and Metabolism

Volumn 6, Issue 4, 2004, Pages 293-298

  Bailey, C J ^a   Turner, S L ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Glucosamine; Glucose toxicity; Insulin resistance; Metformin; Muscle cells; Peroxovanadium; Pinitol

Indexed keywords

DEOXYGLUCOSE; GLUCOSAMINE; GLUCOSE; INSULIN; METFORMIN; TRYPAN BLUE; VANADIUM DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INCUBATION TIME; INSULIN RESISTANCE; MUSCLE CELL; MUSCLE FIBRIL; NONHUMAN; RAT;

EID: 3042640765     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1462-8902.2004.00350.x     Document Type: Article

References (34)

1. Rossetti L, Giaccara A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13: 610-630.
2. Yki-Jarvinen H. Glucose toxicity. Endocr Rev 1992; 13: 415-431.
3. Simonson DC, Rossetti L, Giaccari A et al. Glucose toxicity. In: Alberti KGMM, Zimmet P, DeFronzo RA Keen H eds. International Textbook of Diabetes Mellitus, 2nd edn. Chichester: Wiley, 1997; 713-744.
4. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitisation of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991; 266: 4706-4712.
5. McClain DA, Crook ED. Hexosamines and insulin resistance. Diabetes 1996; 45: 1003-1009.
6. Marshall S, Garvey WT, Traxinger RR. New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids. FASEB 1991; 5: 3031-3036.
7. Sayeski PP, Kudlow JE. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription. J Biol Chem 1996; 271: 15237-15243.
8. Wells L, Vosseller K, Hart GW. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 2001; 291: 2376-2378.
9. Obici S, Wang J, Chowdury R et al. Identification of a biochemical link between energy intake and energy expenditure. J Clin Invest 2002; 109: 1599-1605.
10. Herbert LF, Daniels MC, Zhou J et al. Overexpression of glutamine: fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 1996; 98: 930-936.
11. Crook ED, Daniels MC, Smith TM, McClain DA. Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine: fructose-6-phosphate amidotransferase in rat-1 fibroblasts. Diabetes 1993; 42: 1289-1296.
12. Robinson K-A, Weinstein MI, Lindenmayer GE, Buse MG. Effects of diabetes and hyperglycaemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 1995; 44: 1438-1446.
13. Buse MG, Robinson KA, Gettys TW et al. Increased activity of the hexamine synthesis pathway in muscles of insulin-resistant ob/ob mice. Am J Physiol 1997; 272: E1080-E1088.
14. Yki-Jarvinen H, Daniels MC, Virkamaki A et al. Increased glutamine: fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM. Diabetes 1996; 45: 302-307.
15. Daniels MC, Ciaraldi TP, Nikoulina S et al. Glutamine: fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. J Clin Invest 1996; 97: 1235-1241.
16. Rossetti L. Perspective: hexosamines and nutrient sensing. Endocrinology 2000; 141: 1922-1925.
17. Baron AD, Zhu JS, Zhu JH et al. Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle: implications for glucose toxicity. J Clin Invest 1995; 96: 2792-2801.
18. Cooksey RC, Herbert LF, Zhu JH et al. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine: fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology 1999; 140: 1151-1157.
19. Crook ED, Zhou J, Daniels M et al. Regulation of glycogen synthase by glucose, glucosamine and glutamine: fructose-6-phosphate amidotransferase. Diabetes 1995; 44: 314-320.
20. Patti ME, Virkamaka A, Landaker EJ et al. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signalling events in skeletal muscle. Diabetes 1999; 48: 1562-1571.
21. Kim YB, Zhu JS, Zierath JR et al. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Diabetes 1999; 48: 310-320.
22. James LR, Tang D, Ingram A et al. Flux through the hexosamine pathway is a determinant of nuclear factor KB-dependent promoter activation. Diabetes 2002; 51: 1146-1156.
23. Rossetti L, Hawkins M, Chen W et al. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not hyperglycemic conscious rats. J Clin Invest 1995; 96: 132-140.
24. Virkamaki A, Daniels MC, Hamalainen S et al. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin-sensitive tissues. Endocrinology 1997; 138: 2501-2507.
25. Monauni T, Zenti MG, Cretti A et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 2000; 49: 926-935.
26. Baron AD, Bretchel G, Wallace P et al. Rates and tissue sites of non-insulin and insulin-mediated glucose uptake in humans. Am J Physiol 1988; 255: E769-E774.
27. Klip A, Paquet M. Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 1990; 13: 228-243.
28. Yaffe D. Retention and differentiation potentialities during prolonged cultivation of myogenic cells. Proc Natl Acad Sci USA 1968; 61: 477-483.
29. Bates SH, Jones RB, Bailey CJ. Insulin-like effect of pinitol. Br J Pharmacol 2000; 130: 1944-1948.
30. Bates SH, Gardiner JV, Jones RB, Bloom SR, Bailey CJ. Acute stimulation of glucose uptake by leptin in L6 muscle cells. Horm Metab Res 2002; 34: 111-115.
31. Zhou G, Myers R, Li Y et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-1174.
32. El-Mir M-Y, Nogueira V, Fontaine E, Averet N et al. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 2000; 275: 223-228.
33. Wiernsperger NF, Bailey CJ. The antihyperglycaemic effect of metformin. Therapeutic and cellular mechanisms. Drugs 1999; 58 (Suppl. 1): 31-39.
34. Tsiani E, Bogdanovic E, Sorisky A, Nagy L, Fantus IG. Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C. Diabetes 1998; 47: 1676-1686.